Tucson's health community is getting an upgrade. Some feel the revival of the heart transplant program will make UAMC an international leader once again in heart transplants and research.
June is National Men’s Health Month and National CPR & AED Awareness Month
The University of Arizona Medical Center – University Campus has reactivated its Heart Transplant Program after receiving approval from the United Network of Organ Sharing (UNOS).
Dr. Slepian and Danny Bluestein, PhD, professor of bioengineering at Stony Brook University in New York, co-authored a review article in the New England Journal of Medicine (April 17, 2014), citing the benefits of hydrophobic light-activated adhesive (HLAA), a fluid, blood-resistant tissue glue that can be applied as a liquid before a procedure is performed and activated on demand to adhere, cure and bond.
The UV light-activated adhesive created a water-tight seal in seconds that stayed intact in the face of high pressure and flowing blood but biodegrades over time, explained Danny Bluestein, PhD, of New York's Stony Brook University, and Marvin J. Slepian, MD, of the Sarver Heart Center in Tucson, Ariz.
Researchers at the University of Arizona are working on a new way to power pacemakers that could do away with batteries for good.
Marvin H. Slepian, MD, a cardiologist at the University of Arizona Sarver Heart Center, and his colleagues are part of an interdisciplinary research team, including scientists from Northwestern University and the University of Illinois, who are developing a flexible medical implant that harvests the energy of the beating heart. Such a device could power pacemakers, defibrillators and heart-rate monitors naturally and reliably and reduce or eliminate the need for batteries.
Nancy K. Sweitzer, MD, PhD, director of the University of Arizona Sarver Heart Center and chief of the Division of Cardiology at the UA College of Medicine – Tucson serves on the TOPCAT executive committee.
Nancy K. Sweitzer, MD, PhD, is among the heart experts providing an update on heart disease-related medications and technology.
Dr. Nancy Sweitzer, a cardiologist and physiologist recognized for her leadership and experience in clinical heart disease research, focused on her specialty of clinical trials in treating heart disease.